Sinovac Biotech logo

SVA - Sinovac Biotech News Story

$6.47 0.0  0.0%

Last Trade - 22/02/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £190.1m
Position in Universe th / 6849

Refinitiv Newscasts - Chile hails 'game-changer' Sinovac data

Sat 17th April, 2021 12:59pm
Click the following link to watch video: https://share.newscasts.refinitiv.com/link?entryId=1_j2nxamai&referenceId=tag:reuters.com,2021:newsml_OVE8X0YNF_K15&pageId=RefinitivNewscasts
Source: Thomson Reuters

Description: Sinovac's CoronaVac is 67% effective in preventing symptomatic
infection and 85% effective in preventing hospitalizations, the first
real-world study of the Chinese shot has shown. Chile, where the trial took
place, hailed it as a game-changer. Lucy Fielder reports.
Short Link: https://refini.tv/3e7MG8V

Video Transcript:

Verified transcript not available
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.